Cargando…
Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report
The anti-CV2/CRMP5 antibody is a well-characterized biomarker of paraneoplastic neurological syndrome. The anti-NF186 antibody is a recently discovered antibody associated with central or peripheral demyelination. The co-occurrence of these two antibodies has not been reported. Herein, we report a c...
Autores principales: | Liu, Bingyou, Zhou, Lei, Zheng, Yongsheng, Sun, Chong, Lin, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046875/ https://www.ncbi.nlm.nih.gov/pubmed/36979184 http://dx.doi.org/10.3390/brainsci13030374 |
Ejemplares similares
-
Paraneoplastic Limbic Encephalitis Associated with Anti-CV2/CRMP5 Antibodies Secondary to Thymoma in an Adolescent
por: Ibrahim Ismail, Ismail, et al.
Publicado: (2020) -
Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine
por: Ha, Jongmok, et al.
Publicado: (2019) -
An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes
por: Wang, Sai, et al.
Publicado: (2023) -
Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature
por: Juárez-Vignon Whaley, Juan José, et al.
Publicado: (2021) -
Clinical profile of autoimmune nodopathy with anti‐neurofascin 186 antibody
por: Liu, Bingyou, et al.
Publicado: (2023)